Colorcon® is a world leader in the development, supply and support of formulated products for the pharmaceutical industry. Our core businesses include film coatings, modified release technologies, functional excipients and tablet design services.
Location: United States, Pennsylvania, Lower Salford Township
Employees: 1001-5000
Total raised: $50M
Founded date: 1961
Investors 1
| Date | Name | Website |
| - | Berwind | berwind.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.09.2019 | - | $50M | - |
Mentions in press and media 15
| Date | Title | Description |
| 24.07.2025 | Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia | Johor plant is Colorcon's 7th major film coating plant and 16th manufacturing facility worldwide HARLEYSVILLE, Pa. and JOHOR, Malaysia, July 24, 2025 /PRNewswire/ -- Colorcon, a global leader of film coating systems, specialty excipients, c... |
| 09.07.2025 | Syntis Bio Secures $38M Series A, Accelerates Oral Therapy Pipeline | Syntis Bio, a Boston biopharma, secured $38M Series A funding led by Cerberus Ventures. An additional $5M from NIH non-dilutive grants was also obtained. This substantial capital propels the development of oral therapies for obesity, diabet... |
| 07.07.2025 | Syntis Bio raises $38 million | Syntis Bio, Syntis Bio Founded: 2022 Headquarters: Boston, Massachusetts, United States Total Funding: $53.37M See full company profile "> a Boston-based obesity, diabetes, and rare diseases oral therapies developer, announced the c... |
| 08.05.2025 | Colorcon and ASHA Cellulose Announce New Partnership to Support the Development & Manufacture of Barrier Membrane Formulations for the Pharmaceutical and Nutraceutical Industries | HARLEYSVILLE, Pa. and MUMBAI, India, May 8, 2025 /PRNewswire/ -- Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the healthcare industry, today... |
| 06.03.2024 | Sustained Release Excipients Global Market Report 2024: A Review of 2018-2023 with Forecasts Through 2024-2028 & 2033 by Product, Route of Administration, Technology and Region | - |
| 06.06.2023 | Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia | Establishment of an eighth Colorcon film coating facility meets the expanding needs of the pharmaceutical and nutritional sectors in Southeast Asia HARLEYSVILLE, Pa., June 6, 2023 /PRNewswire/ -- Colorcon, Inc. is proud to formally announce... |
| 13.09.2022 | Novome gets $43.5M boost for its engineered microbiome therapies | Novome Biotechnologies — a South San Francisco-based biotech focused on genetically engineered microbial medicines (GEMMs) — raised $43.5 million in Series B funds on Tuesday. The funding round was led by Tencent. Other investors — Universi... |
| 19.05.2021 | Colorcon Expands Pharmaceutical Development Capabilities with a New Containment Suite for Handling High Potency APIs at its Global Technical Center in Harleysville, PA, USA | |
| 12.03.2021 | How to Select the Right Polymers for your Modified Release Tablet or Capsule, Upcoming Webinar Hosted by Xtalks | Often, modified release (MR) formulations offer patient compliance, marketing and exclusivity/patent benefits over immediate-release versions. What isn’t as obvious is that MR dosage forms present their own unique set of complications aroun... |
| 23.02.2021 | Colorcon, Inc. Launches Nutrafinish® Label Friendly Tablet Coatings for Nutritional Supplements Market |
Show more